Suppr超能文献

白细胞移动抑制试验(L.M.T)在子宫颈癌中的应用(作者译)

[The utilisation of the leukocyte migration inhibition test (L.M.T) in carcinoma of cervix uteri (author's transl)].

作者信息

Schmeisser G, Kademann J

出版信息

Arch Geschwulstforsch. 1980;50(2):169-72.

PMID:7436701
Abstract

The leukocyte migration inhibition test (L.M.T.) was utilized for in vitro studies of cell mediated immunity in gynecologic malignomas. Autogenous peripheral blood leukocytes from 50 patients with a carcinoma of the cervix uteri were studied in about 100 tests. There was found an inhibition of the migration of the autogenous leukocytes in 25 of 47 tests of patients with a CCI without evidence of metastasis or widespread disease. However, the migration of autogenous leukocytes from patients with metastasis or widespread disease (CCII) were only inhibited in 14 of 46 cases. At normal tissue were inhibited in 15 of 89 cases the migration of the autogenous leukocytes.

摘要

白细胞游走抑制试验(L.M.T.)被用于妇科恶性肿瘤细胞介导免疫的体外研究。对50例子宫颈癌患者的自体外周血白细胞进行了约100次检测。在47例无转移或广泛疾病证据的CCI患者的检测中,有25例发现自体白细胞游走受到抑制。然而,有转移或广泛疾病(CCII)患者的自体白细胞游走仅在46例中的14例受到抑制。在89例正常组织检测中,有15例自体白细胞游走受到抑制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验